About: covid:PMC7273950

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7273950 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Huang, Ying Zhou, Ying Kang, Ben Kappelman, Michael Uhlig, Holm Aloi, Marina Dias, Jorge Focht, Gili Ledder, Oren Lionetti, Paolo Martín-de-Carpi, Javier Pujol-Muncunill, Gemma Ruemmele, Frank Russell, Richard Sanchez, Cesar Turner, Dan
is schema:about of	named entity 'Hepatology' named entity 'Virus' named entity 'Paediatric' named entity 'IBD' named entity 'GLOBAL' named entity 'GUIDANCE' named entity 'GROUP' named entity 'PORTO' named entity 'HEPATOLOGY' named entity 'IBD' named entity 'CORONA' named entity 'Corona' named entity 'IBD' named entity 'Hepatology' named entity 'Inflammatory Bowel Diseases' named entity 'March 2020' named entity 'biologics' named entity 'SARS-CoV-2' named entity 'Gyeonsangbuk-do' named entity 'Research Ethics' named entity 'Northern Italy' named entity 'Daegu' named entity 'immunosuppression' named entity 'COVID-19' named entity 'infliximab' named entity 'therapeutic strategies' named entity 'drug administration' named entity 'paediatric gastroenterology' named entity 'demographic' named entity 'electronic voting' named entity 'COVID-19 outbreak' named entity 'follow-up' named entity 'Europe' named entity 'paediatric' named entity 'infection' named entity 'COVID-19' named entity 'virus' named entity 'infection' named entity 'pediatric' named entity 'immunosuppressive medications' named entity 'asymptomatic' named entity 'Crohn disease' named entity 'COVID-19 infection' named entity 'Porto' named entity 'Porto' named entity 'Canada' named entity 'France' named entity 'COVID-19' named entity 'Jerusalem' named entity 'vedolizumab' named entity 'paediatric' named entity 'Zhengzhou' named entity 'South Korea' named entity 'infliximab' named entity 'South Korea' named entity 'infection' named entity 'COVID-19' named entity '10.4' named entity 'COVID-19 outbreak' named entity 'combination therapy' named entity 'general population' named entity 'COVID-19 pandemic' named entity 'SARS-CoV-2' named entity '11.5' named entity 'Nanjing' named entity 'standard of care' named entity 'Chengdu' named entity 'Xiamen' named entity 'infection' named entity 'Xi’an' named entity 'Wuhan' named entity 'SARS-CoV-2' named entity 'endoscopic procedures' named entity 'Chongqing' named entity 'liver disease' named entity 'Israel' named entity 'Coronavirus' named entity 'Gyeonsangbuk-do' named entity 'anxiety' named entity 'immunosuppressive medications' named entity 'infection' named entity 'Israel' named entity 'immunomodulators' named entity 'ethics committee'

Attributes

Values

Creator

Huang, Ying
Zhou, Ying
Kang, Ben
Kappelman, Michael
Uhlig, Holm
Aloi, Marina
Dias, Jorge
Focht, Gili
Ledder, Oren
Lionetti, Paolo
Martín-de-Carpi, Javier
Pujol-Muncunill, Gemma
Ruemmele, Frank
Russell, Richard
Sanchez, Cesar
Turner, Dan

is schema:about of

named entity 'Hepatology'
named entity 'Virus'
named entity 'Paediatric'
named entity 'IBD'
named entity 'GLOBAL'
named entity 'GUIDANCE'
named entity 'GROUP'
named entity 'PORTO'
named entity 'HEPATOLOGY'
named entity 'IBD'
named entity 'CORONA'
named entity 'Corona'
named entity 'IBD'
named entity 'Hepatology'
named entity 'Inflammatory Bowel Diseases'
named entity 'March 2020'
named entity 'biologics'
named entity 'SARS-CoV-2'
named entity 'Gyeonsangbuk-do'
named entity 'Research Ethics'
named entity 'Northern Italy'
named entity 'Daegu'
named entity 'immunosuppression'
named entity 'COVID-19'
named entity 'infliximab'
named entity 'therapeutic strategies'
named entity 'drug administration'
named entity 'paediatric gastroenterology'
named entity 'demographic'
named entity 'electronic voting'
named entity 'COVID-19 outbreak'
named entity 'follow-up'
named entity 'Europe'
named entity 'paediatric'
named entity 'infection'
named entity 'COVID-19'
named entity 'virus'
named entity 'infection'
named entity 'pediatric'
named entity 'immunosuppressive medications'
named entity 'asymptomatic'
named entity 'Crohn disease'
named entity 'COVID-19 infection'
named entity 'Porto'
named entity 'Porto'
named entity 'Canada'
named entity 'France'
named entity 'COVID-19'
named entity 'Jerusalem'
named entity 'vedolizumab'
named entity 'paediatric'
named entity 'Zhengzhou'
named entity 'South Korea'
named entity 'infliximab'
named entity 'South Korea'
named entity 'infection'
named entity 'COVID-19'
named entity '10.4'
named entity 'COVID-19 outbreak'
named entity 'combination therapy'
named entity 'general population'
named entity 'COVID-19 pandemic'
named entity 'SARS-CoV-2'
named entity '11.5'
named entity 'Nanjing'
named entity 'standard of care'
named entity 'Chengdu'
named entity 'Xiamen'
named entity 'infection'
named entity 'Xi’an'
named entity 'Wuhan'
named entity 'SARS-CoV-2'
named entity 'endoscopic procedures'
named entity 'Chongqing'
named entity 'liver disease'
named entity 'Israel'
named entity 'Coronavirus'
named entity 'Gyeonsangbuk-do'
named entity 'anxiety'
named entity 'immunosuppressive medications'
named entity 'infection'
named entity 'Israel'
named entity 'immunomodulators'
named entity 'ethics committee'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software